[1] Patel AK, Reddy V, Shumway KR, et al.
Physiology, Sleep Stages. In: StatPearls. Treasure Island (FL): StatPearls
Publishing; 2025.
[2] De Longis E, Kassis A, Rémond-Derbez N, Thota
R, Darimont C, Donato-Capel L, Hudry J. Cognitive benefits of sleep: a
narrative review to explore the relevance of glucose regulation. Sleep Adv.
2024 Dec 18;6(1):zpae095. doi: 10.1093/sleepadvances/zpae095.
[3] Navakkode S, Kennedy BK. Neural ageing and
synaptic plasticity: prioritizing brain health in healthy longevity. Front
Aging Neurosci. 2024 Aug 5;16:1428244. doi: 10.3389/fnagi.2024.1428244.
[4] Bjorness TE, Greene RW. Adenosine and sleep.
Curr Neuropharmacol. 2009 Sep;7(3):238-45. doi: 10.2174/157015909789152182.
[5] Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation:
state of the science and perspectives. J Sleep Res. 2022 Aug;31(4):e13597. doi:
10.1111/jsr.13597.
[6] Pieramico V, Esposito R, Cesinaro S, Frazzini
V, Sensi SL. Effects of non-pharmacological or pharmacological interventions on
cognition and brain plasticity of aging individuals. Front Syst Neurosci. 2014
Sep 2;8:153. doi: 10.3389/fnsys.2014.00153.
[7] Camberos-Barraza, J., Camacho-Zamora, A.,
Bátiz-Beltrán, J. C., Osuna-Ramos, J. F., Rábago-Monzón, Á. R., Valdez-Flores,
M. A., Angulo-Rojo, C. E., Guadrón-Llanos, A. M., Picos-Cárdenas, V. J.,
Calderón-Zamora, L., Norzagaray-Valenzuela, C. D., Cárdenas-Torres, F. I.,
& De la Herrán-Arita, A. K. Sleep, Glial Function, and the Endocannabinoid
System: Implications for Neuroinflammation and Sleep Disorders. International
Journal of Molecular Sciences, 2024;25(6), 3160.
[8] Lavoie, C.J., Zeidler, M.R. & Martin, J.L.
Sleep and aging. Sleep Science Practice, 2018; 2, 3:12-23.
[9] Zhao W, Van Someren EJW, Li C, Chen X, Gui W,
Tian Y, Liu Y, Lei X. EEG spectral analysis in insomnia disorder: A systematic
review and meta-analysis. Sleep Med Rev. 2021 Oct;59:101457. doi:
10.1016/j.smrv.2021.101457
[10]
iper
DC, Upton N, Smith MI, Hunter AJ. The
novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur
J Neurosci. 2000 Feb;12(2):726-30. doi: 10.1046/j.1460-9568.2000.00919.x.
[11]
Rahman SA,
Gathungu RM, Marur VR, St Hilaire MA, Scheuermaier K, Belenky M, Struble JS,
Czeisler CA, Lockley SW, Klerman EB, Duffy JF, Kristal BS. Age-related changes
in circadian regulation of the human plasma lipidome. Commun Biol. 2023 Jul
20;6(1):756. doi: 10.1038/s42003-023-05102-8.
[12]
Eiser AS.
Sleep-Related Dissociative Disorders. Sleep Med Clin. 2024 Mar;19(1):159-167.
doi: 10.1016/j.jsmc.2023.10.003.
[13]
Wolff CA,
Gutierrez-Monreal MA, Meng L, Zhang X, Douma LG, Costello HM, Douglas CM,
Ebrahimi E, Pham A, Oliveira AC, Fu C, Nguyen A, Alava BR, Hesketh SJ, Morris
AR, Endale MM, Crislip GR, Cheng KY, Schroder EA, Delisle BP, Bryant AJ, Gumz
ML, Huo Z, Liu AC, Esser KA. Defining the age-dependent and tissue-specific
circadian transcriptome in male mice. Cell Rep. 2023 Jan 31;42(1):111982. doi:
10.1016/j.celrep.2022.111982.
[14]
Baird B,
Aparicio MK, Alauddin T, Riedner B, Boly M, Tononi G. Episodic thought
distinguishes spontaneous cognition in waking from REM and NREM sleep.
Conscious Cogn. 2022 Jan;97:103247. doi: 10.1016/j.concog.2021.103247.
[15]
Sang D,
Lin K, Yang Y, Ran G, Li B, Chen C, Li Q, Ma Y, Lu L, Cui XY, Liu Z, Lv SQ, Luo
M, Liu Q, Li Y, Zhang EE. Prolonged sleep deprivation induces a
cytokine-storm-like syndrome in mammals. Cell. 2023 Dec
7;186(25):5500-5516.e21. doi: 10.1016/j.cell.2023.10.025.
[16]
Kreider
MS, Winokur A, Pack AI, Fishman AP. Reduction of thyrotropin-releasing hormone
concentrations in central nervous system of African lungfish during estivation.
Gen Comp Endocrinol. 1990 Mar;77(3):435-41. doi: 10.1016/0016-6480(90)90234-d.
[17]
Xu H, Qiu
Q, Hu P, Hoxha K, Jang E, O'Reilly M, Kim C, He Z, Marotta N, Changolkar L,
Zhang B, Wu H, Schellenberg GD, Kraemer B, Luk KC, Lee EB, Trojanowski JQ,
Brunden KR, Lee VM. MSUT2 regulates tau spreading via adenosinergic signaling
mediated ASAP1 pathway in neurons. Acta Neuropathol. 2024 Mar 12;147(1):55.
doi: 10.1007/s00401-024-02703-3.
[18]
Facco FL,
Wolsk J, Patel SR, Hubel C, Gallaher M, Cashmere JD, Wisniewski S. A trial of
positive airway pressure for the treatment of sleep apnea in pregnancy. Am J
Obstet Gynecol MFM. 2023 Mar;5(3):100840. doi: 10.1016/j.ajogmf.2022.100840.
[19]
Falup-Pecurariu
C, Muntean ML, Ungureanu L, Murasan I, Popławska-Domaszewicz K, Chaudhuri KR,
Diaconu S. Pharmacological and non-pharmacological management of sleep
disturbances in Parkinson's disease: if when and how. Expert Opin Pharmacother.
2024 Nov;25(16):2135-2149. doi: 10.1080/14656566.2024.2422004.
[20]
Yang Q,
Cai Y, Ma Q, Xiong A, Xu P, Zhang Z, Xu J, Zhou Y, Liu Z, Zhao D, Asara J, Li
W, Shi H, Caldwell RB, Sodhi A, Huo Y. Inactivation of adenosine receptor 2A
suppresses endothelial-to-mesenchymal transition and inhibits subretinal
fibrosis in mice. Sci Transl Med. 2024 Mar 6;16(737):eadk3868. doi:
10.1126/scitranslmed.adk3868.
[21]
Cavalu S,
Saber S, Hamad RS, Abdel-Reheim MA, Elmorsy EA, Youssef ME. Orexins in
apoptosis: a dual regulatory role. Front Cell Neurosci. 2024 Apr 12;18:1336145.
doi: 10.3389/fncel.2024.1336145.
[22]
Imamura K,
Akagi KI, Miyanoiri Y, Tsujimoto H, Hirokawa T, Ashida H, Murakami K, Inoue A,
Suno R, Ikegami T, Sekiyama N, Iwata S, Kobayashi T, Tochio H. Interaction
modes of human orexin 2 receptor with selective and nonselective antagonists
studied by NMR spectroscopy. Structure. 2024 Mar 7;32(3):352-361.e5. doi:
10.1016/j.str.2023.12.008.
[23]
Wang Q,
Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging
Neurosci. 2021 Aug 17;13:713201. doi: 10.3389/fnagi.2021.713201.
[24]
Branch AF,
Navidi W, Tabuchi S, Terao A, Yamanaka A, Scammell TE, Diniz Behn C.
Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness.
Sleep. 2016 Feb 1;39(2):369-77. doi: 10.5665/sleep.5446.
[25]
Rocha RB,
Bomtempo FF, Nager GB, Cenci GI, Telles JPM. Dual orexin receptor antagonists
for the treatment of insomnia: systematic review and network meta-analysis. Arq
Neuropsiquiatr. 2023 May;81(5):475-483. doi: 10.1055/s-0043-1768667.
[26]
Li F, Yan
Y, Zheng L, Wang C, Guan X, Hong S, Guo H. Frailty and its combined effects
with lifestyle factors on cognitive function: a cross-sectional study. BMC
Geriatr. 2023 Feb 6;23(1):79. doi: 10.1186/s12877-023-03761-0.
[27]
Bouâouda
H, Jha PK. Orexin and MCH neurons: regulators of sleep and metabolism. Front
Neurosci. 2023 Aug 22;17:1230428. doi: 10.3389/fnins.2023.1230428.
[28]
Ghit A,
Assal D, Al-Shami AS, Hussein DEE. GABAA receptors: structure,
function, pharmacology, and related disorders. J Genet Eng Biotechnol. 2021 Aug
21;19(1):123. doi: 10.1186/s43141-021-00224-0.
[29]
Xiang T,
Liao J, Cai Y, Fan M, Li C, Zhang X, Li H, Chen Y, Pan J. Impairment of GABA
inhibition in insomnia disorders: Evidence from the peripheral blood system.
Front Psychiatry. 2023 Feb 9;14:1134434. doi: 10.3389/fpsyt.2023.1134434.
[30]
Neumann E,
Rudolph U, Knutson DE, Li G, Cook JM, Hentschke H, Antkowiak B, Drexler B.
Zolpidem Activation of Alpha 1-Containing GABAA Receptors
Selectively Inhibits High Frequency Action Potential Firing of Cortical
Neurons. Front Pharmacol. 2019 Jan 9;9:1523. doi:
10.3389/fphar.2018.01523.
[31]
McCall WV.
Sleep in the Elderly: Burden, Diagnosis, and Treatment. Prim Care Companion J
Clin Psychiatry. 2004;6(1):9-20. doi: 10.4088/pcc.v06n0104.
[32]
Wang W, Fu
W, Zhu H, Ma J, Zhang J, Qi J. Progress in GABAA receptor agonists for insomnia
disorder. Front Pharmacol. 2024 Nov 5;15:1432726. doi:
10.3389/fphar.2024.1432726.
[33]
Gottesmann
C. GABA mechanisms and sleep. Neuroscience. 2002;111(2):231-9. doi:
10.1016/s0306-4522(02)00034-9.
[34]
Joiner WJ.
The Neurobiological Basis of Sleep and Sleep Disorders. Physiology (Bethesda).
2018 Sep 1;33(5):317-327. doi: 10.1152/physiol.00013.2018.
[35]
De Luca R,
Nardone S, Grace KP, Venner A, Cristofolini M, Bandaru SS, Sohn LT, Kong D,
Mochizuki T, Viberti B, Zhu L, Zito A, Scammell TE, Saper CB, Lowell BB, Fuller
PM, Arrigoni E. Orexin neurons inhibit sleep to promote arousal. Nat Commun.
2022 Jul 18;13(1):4163. doi: 10.1038/s41467-022-31591-y.
[36]
Kumar S,
Rai S, Hsieh KC, McGinty D, Alam MN, Szymusiak R. Adenosine A(2A) receptors
regulate the activity of sleep regulatory GABAergic neurons in the preoptic
hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2013 Jul 1;305(1):R31-41.
doi: 10.1152/ajpregu.00402.2012.
[37]
Blanco-Centurion
C, Xu M, Murillo-Rodriguez E, Gerashchenko D, Shiromani AM, Salin-Pascual RJ,
Hof PR, Shiromani PJ. Adenosine and sleep homeostasis in the Basal forebrain. J
Neurosci. 2006 Aug 2;26(31):8092-100. doi: 10.1523/JNEUROSCI.2181-06.2006.
[38]
Hassan M,
Adotevi NK, Leitch B. Altered GABAA Receptor Expression in the
Primary Somatosensory Cortex of a Mouse Model of Genetic Absence Epilepsy. Int
J Mol Sci. 2022 Dec 10;23(24):15685. doi: 10.3390/ijms232415685.
[39]
Tsuboi D,
Nagai T, Yoshimoto J, Kaibuchi K. Neuromodulator regulation and emotions:
insights from the crosstalk of cell signaling. Front Mol Neurosci. 2024 Mar
7;17:1376762. doi: 10.3389/fnmol.2024.1376762.
[40]
Álamo C,
Sáiz Ruiz J, Zaragozá Arnáez C. Orexinergic Receptor Antagonists as a New
Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment
of Insomnia Disorder. Actas Esp Psiquiatr. 2024 Apr;52(2):172-182. doi:
10.62641/aep.v52i2.1659.
[41]
Liu J,
Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML.
MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. Annu Rev Pharmacol
Toxicol. 2016;56:361-83. doi: 10.1146/annurev-pharmtox-010814-124742.
[42]
Rémi J,
Pollmächer T, Spiegelhalder K, Trenkwalder C, Young P. Sleep-Related Disorders
in Neurology and Psychiatry. Dtsch Arztebl Int. 2019 Oct 11;116(41):681-688.
doi: 10.3238/arztebl.2019.0681.
[43]
Gu HJ, Lee
OS. Effects of Non-Pharmacological Sleep Interventions in Older Adults: A
Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2023 Feb
10;20(4):3101. doi: 10.3390/ijerph20043101.
[44]
Voicu V,
Toader C, Șerban M, Covache-Busuioc RA, Ciurea AV. Systemic Neurodegeneration
and Brain Aging: Multi-Omics Disintegration, Proteostatic Collapse, and Network
Failure Across the CNS. Biomedicines. 2025 Aug 20;13(8):2025. doi:
10.3390/biomedicines13082025.
[45]
Simmonds
E, Levine KS, Han J, Iwaki H, Koretsky MJ, Kuznetsov N, Faghri F, Solsberg CW,
Schuh A, Jones L, Bandres-Ciga S, Blauwendraat C, Singleton A, Escott-Price V,
Leonard HL, Nalls MA. Sleep disturbances as risk factors for neurodegeneration
later in life. medRxiv [Preprint]. 2023 Nov 9:2023.11.08.23298037. doi:
10.1101/2023.11.08.23298037.
[46]
Xia L, Liu
H, Ren J. A review of symptom, pathogenesis and treatment characteristics of
the elderly with chronic insomnia. Medicine (Baltimore). 2025 Jan
31;104(5):e41346. doi: 10.1097/MD.0000000000041346.
[47]
Scammell
TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities.
Annu Rev Pharmacol Toxicol. 2011;51:243-66. doi:
10.1146/annurev-pharmtox-010510-100528.
[48]
Wang C,
Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System:
Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front
Mol Neurosci. 2018 Jun 28;11:220. doi: 10.3389/fnmol.2018.00220.
[49]
Varinthra
P, Anwar SNMN, Shih SC, Liu IY. The role of the GABAergic system on insomnia.
Tzu Chi Med J. 2024 Mar 26;36(2):103-109. doi: 10.4103/tcmj.tcmj_243_23.
[50]
Uygun DS,
Yang C, Tilli ER, Katsuki F, Hodges EL, McKenna JT, McNally JM, Brown RE,
Basheer R. Knockdown of GABAA alpha3 subunits on thalamic
reticular neurons enhances deep sleep in mice. Nat Commun. 2022 Apr
26;13(1):2246. doi: 10.1038/s41467-022-29852-x.
[51]
Reichert,
C.F.; Maire, M.; Schmidt, C.; Cajochen, C. Sleep-Wake Regulation and Its Impact
on Working Memory Performance: The Role of Adenosine. Biology 2016, 5,
11.
[52]
Thakkar
MM. Histamine in the regulation of wakefulness. Sleep Med Rev. 2011
Feb;15(1):65-74. doi: 10.1016/j.smrv.2010.06.004.
[53]
Berridge
CW. Noradrenergic modulation of arousal. Brain Res Rev. 2008 Jun;58(1):1-17.
doi: 10.1016/j.brainresrev.2007.10.013.
[54]
Targa ADS,
Noseda ACD, Rodrigues LS, Aurich MF, Lima MMS. REM sleep deprivation and
dopaminergic D2 receptors modulation increase recognition memory in an animal
model of Parkinson's disease. Behav Brain Res. 2018 Feb 26;339:239-248. doi:
10.1016/j.bbr.2017.11.008.
[55]
Ferreira-Vieira
TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer's disease: Targeting the
Cholinergic System. Curr Neuropharmacol. 2016;14(1):101-15. doi:
10.2174/1570159x13666150716165726.
[56]
Mackiewicz
M, Nikonova EV, Zimmermann JE, Romer MA, Cater J, Galante RJ, Pack AI. Age-related changes in adenosine metabolic
enzymes in sleep/wake regulatory areas of the brain. Neurobiol Aging. 2006
Feb;27(2):351-60. doi: 10.1016/j.neurobiolaging.2005.01.015.
[57]
Ragsdale
SM, Radovich JM, Coiduras II, McCall WV, Grant SC, Lee C, Wilber A. Dual orexin
receptor antagonists as promising therapeutics for Alzheimer's disease. NPJ
Biol Timing Sleep. 2025;2(1):11. doi: 10.1038/s44323-025-00025-5.
[58]
Pereira
AC, Mao X, Jiang CS, Kang G, Milrad S, McEwen BS, Krieger AC, Shungu DC.
Dorsolateral prefrontal cortex GABA deficit in older adults with
sleep-disordered breathing. Proc Natl Acad Sci U S A. 2017 Sep
19;114(38):10250-10255. doi: 10.1073/pnas.1700177114.
[59]
Anghel L,
Baroiu L, Popazu CR, Pătraș D, Fotea S, Nechifor A, Ciubara A, Nechita L, Mușat
CL, Stefanopol IA, Tatu AL, Ciubara AB. Benefits and adverse events of
melatonin use in the elderly (Review). Exp Ther Med. 2022 Mar;23(3):219. doi:
10.3892/etm.2022.11142.
[60]
Cojuc-Konigsberg
G, Schoo C. Inappropriate Medication in the Geriatric Population. In:
StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan